Scrip's Five Must-Know Things - Oct. 6, 2025

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Bayer’s Phase III failure; US group seeks Japan changes; AstraZeneca winning AKT race for now; NASH developments at AASLD; and the Q3 impact of China’s corruption campaig ...  Show more

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Bayer’s Phase III failure; US group seeks Japan changes; AstraZeneca winning AKT race for now; NASH developments at AASLD; and the Q3 impact of China’s corruption campaig ...  Show more

Kara Swisher, Host of "Sway" and "Pivot" podcasts, Contributing Opinion Writer for NYT, and Co-Founder of Recode, joins Dan Loney to talk about last week's Wharton Analytics Conference during which she spoke about algorithms, how the pandemic has accelerated certain tech trends, ...  Show more

Innovation and interest in the tech sector remain strong, despite market challenges and dips in investment. On this episode of The McKinsey Podcast, McKinsey technology experts Lareina Yee and Roger Roberts share findings from the McKinsey Technology Trends Outlook 2024 report. T ...  Show more

What’s next for cancer treatment and personalized medicine? How is AI reshaping the future of drug discovery? And can Europe keep pace with China’s rapid rise in health care innovation? In this episode, Nicolai welcomes Thomas Schinecker, CEO of Roche, one of the world’s large ...

2021 was a busy year for IIBA (International Institute of Business Analysis). In this episode Scott and Susan talk about 2021 news, trends and updates from IIBA and we talk about the things coming up in 2022 for our organization. 

Click to learn more about the topi ...